Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Polycystic Ovary Syndrome 16Hyperandrogenism 6Endometrial Neoplasms 4Endometrial Hyperplasia 2Breast Neoplasms 2Uterine Cervical Dysplasia 1Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Progesterone Resistance 1Osteoporosis 1Obesity 1Infertility, Female 1Gliosarcoma 1Glioblastoma 1Coronary Disease 1Cardiovascular Diseases 1Brain Neoplasms 1Anovulation 1Abortion, Spontaneous 1

Interventions

Radiosurgery 114Temozolomide 104Bevacizumab 71Radiotherapy 67Magnetic Resonance Spectroscopy 67Carboplatin 29pembrolizumab 28Irinotecan 26Surgical Procedures, Operative 25Radiation 23Nivolumab 23Etoposide 22Magnetic Resonance Imaging 21Ipilimumab 21Erlotinib Hydrochloride 21Cyclophosphamide 21Surveys and Questionnaires 19Aminolevulinic Acid 18Specimen Handling 16Pemetrexed 16Mental Status and Dementia Tests 16Cisplatin 16Carmustine 15Topotecan 14Trastuzumab 13Saline Solution 12Neuropsychological Tests 12Gefitinib 11Filgrastim 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Brain Neoplasms × Progesterone × Clear all
NCT04414020 2020-06-04

Cytoprotective Effect and Clinical Outcome of Perioperative Proesterone in Brain Tumors

Minia University

Phase 1 Unknown
26 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡